Skip to main content

Advertisement

Table 1 Input variables used in estimating health-related economic impact

From: Government use licenses in Thailand: an assessment of the health and economic impacts

Parameters Values References
Thai Gross Domestic Product (GDP) per capita (Baht) 135,220 [43]
Disability Adjusted Life Years (DALYs) averted from EFV-based ARVs treatment 5.69 [44]
DALYs averted from NVP-based ARVs treatment 5.54  
QALYs gained from LPV/r-based ARVs treatment No-data -
QALYs gained from indinavir/ritonavir (IDV/r)-based ARVs treatment No-data -
QALYs gained from clopidogrel plus aspirin, which is used for secondary prevention of ischemic heart disease 7.37 [45]
QALYs gained from aspirin alone, which is used for secondary prevention of ischemic heart disease 7.31  
QALYs gained from letrozole for treatment of breast cancer 13.14 [46]
QALYs gained from tamoxifen for treatment of breast cancer 12.73  
QALYs gained from docetaxel for treatment of breast cancer 0.87 [47]
QALYs gained from paclitaxel for treatment of breast cancer 0.66  
QALYs gained from docetaxel for treatment of lung cancer 0.41 [48]
QALYs gained from pemetrexed for treatment of lung cancer 0.41  
QALYs gained from erlotinib for treatment of lung cancer 0.42 [48]
QALYs gained from imatinib for treatment of Chronic Myeloid Leukemia (CML) 1.07 [49]
QALYs gained from imatinib for treatment of GIST 1.9 [50]